Targeted Drug Trio for Colorectal Cancer with BRAF Mutations - NCI
Identification of actionable alterations in colorectal cancer are leading to the development of novel treatment strategies - Mayo Clinic
Resistance to anti-EGFR therapies in metastatic colorectal cancer: underlying mechanisms and reversal strategies | Journal of Experimental & Clinical Cancer Research | Full Text
Clinical management of metastatic colorectal cancer in the era of precision medicine - Ciardiello - 2022 - CA: A Cancer Journal for Clinicians - Wiley Online Library
Beyond KRAS status and response to anti-EGFR therapy in metastatic colorectal cancer | Pharmacogenomics
Mechanisms of resistance to anti-EGFR therapy in colorectal cancer. - Abstract - Europe PMC
RESISTANCE TO ANTI-EGFR THERAPIES IN COLORECTAL CANCER – Sanguine Bio Researcher Blog
Biomarkers in Targeted Therapy for Colorectal Cancer
Hexameric procyanidins inhibit colorectal cancer cell growth through both redox and non-redox regulation of the epidermal growth factor signaling pathway - ScienceDirect
The Role of the Epidermal Growth Factor Receptor in the Mechanism and Treatment of Colorectal Cancer - Nirit Yarom - Discovery Medicine
EGFR signaling in colorectal cancer: a clinical perspective | GICTT
Polarization of macrophages in the tumor microenvironment is influenced by EGFR signaling within colon cancer cells | Oncotarget
APMG Colon Molecular Pathways
EGFR signaling in colorectal cancer: a clinical perspective | GICTT
![PDF] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/2e5f89dec8a25afc1d61dc3d7197afa33839845d/3-Figure2-1.png "PDF] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer | Semantic Scholar")
PDF] Mechanisms of resistance to anti-EGFR therapy in colorectal cancer | Semantic Scholar
Y‑box‑binding protein 1 inhibits apoptosis and upregulates EGFR in colon cancer
Comprehensive review of targeted therapy for colorectal cancer | Signal Transduction and Targeted Therapy
Primary and acquired resistance to EGFR-targeted therapies in colorectal cancer: impact on future treatment strategies | Journal of Molecular Medicine
Biomarkers in colorectal cancer: Current clinical utility and future perspectives
Feedback activation of EGFR/wild-type RAS signaling axis limits KRASG12D inhibitor efficacy in KRASG12D-mutated colorectal cancer | Oncogene
Epidermal growth factor receptor (EGFR)-related signaling pathway in... | Download Scientific Diagram
Precision medicine for metastatic colorectal cancer in clinical practice - Julian E. Riedesser, Matthias P. Ebert, Johannes Betge, 2022
IJMS | Free Full-Text | Recent Advances in Targeting the EGFR Signaling Pathway for the Treatment of Metastatic Colorectal Cancer
